Clinical trial
TRACE: Tirapazamine-Radiation And Cisplatin Evaluation
NCT00174837 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174837 |
|---|---|
| Title | TRACE: Tirapazamine-Radiation And Cisplatin Evaluation |
| Official title | Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer |
| Acronym | TRACE |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Groupe Oncologie Radiotherapie Tete et Cou |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Squamous Cell Carcinoma |
| Intervention type | Drug |
| Interventions | Tirapazamine, Cisplatin |
| Enrollment | 317 |
| Start date | Apr 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | May 26, 2016 |
| Countries | Argentina, Australia, Canada, Chile, France, Germany, Hong Kong, Hungary, Italy, New Zealand, Poland, Singapore and 5 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: